PubMed

Serum lipids and the progression of nephropathy in type 1 diabetes.

Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Cooper ME, Taskinen MR, Viberti G, Groop PH.

Diabetes Care. 2006 Feb;29(2):317-22.PMID: 16443880 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.

Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group.

Diabetes Care. 2008 Jun;31(6):1165-9. Epub 2008 Mar 17.PMID: 18346990 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P; Casale Monferrato Study.

Diabetes Care. 2003 Jul;26(7):2150-5.PMID: 12832328 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal function in long-duration type I diabetes.

Mackin P, Macleod JM, New JP, Marshall SM.

Diabetes Care. 1996 Mar;19(3):249-51.PMID: 8742571 [PubMed - indexed for MEDLINE]Related articles

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G; DAIS Investigators.

Am J Kidney Dis. 2005 Mar;45(3):485-93.PMID: 15754270 [PubMed - indexed for MEDLINE]Related articles

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.

Mogensen CE.

J Intern Med. 2003 Jul;254(1):45-66. Review.PMID: 12823642 [PubMed - indexed for MEDLINE]Related articles

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.

Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.

Diabetes Care. 1999 Jul;22(7):1176-80.PMID: 10388985 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten CG, Taskinen MR, Groop PH; FinnDiane Study Group.

Diabetes Care. 2005 Aug;28(8):2019-24.PMID: 16043748 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.

Torffvit O, Agardh CD.

J Diabetes Complications. 2001 Nov-Dec;15(6):307-13.PMID: 11711324 [PubMed - indexed for MEDLINE]Related articles

Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan.

Tseng CH.

Clin Biochem. 2009 Jul;42(10-11):1019-24. Epub 2009 Mar 24.PMID: 19324028 [PubMed - indexed for MEDLINE]Related articles

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.PMID: 15799209 [PubMed - indexed for MEDLINE]Related articles

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients.

Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH.

Diabetologia. 2003 Oct;46(10):1402-7. Epub 2003 Aug 20.PMID: 12928771 [PubMed - indexed for MEDLINE]Related articles

Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.

Hadjadj S, Duly-Bouhanick B, Bekherraz A, BrIdoux F, Gallois Y, Mauco G, Ebran J, Marre M.

Diabetes Metab. 2004 Feb;30(1):43-51.PMID: 15029097 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum adiponectin is increased in type 1 diabetic patients with nephropathy.

Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane study group.

Diabetes Care. 2005 Jun;28(6):1410-4.PMID: 15920060 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.

Nayak SB, Bhaktha G.

Lipids Health Dis. 2005 Aug 10;4:15.PMID: 16092968 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.

Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N.

Diabetologia. 2004 Jun;47(6):1020-8. Epub 2004 May 29.PMID: 15170497 [PubMed - indexed for MEDLINE]Related articles

Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.

Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCCT/EDIC Research Group.

Kidney Int. 2003 Sep;64(3):817-28.PMID: 12911531 [PubMed - indexed for MEDLINE]Related articles

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS GROUP.

Kidney Int. 2003 Jan;63(1):225-32.PMID: 12472787 [PubMed - indexed for MEDLINE]Related articles

The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression.

De Cosmo S, Miscio G, Zucaro L, Margaglione M, Argiolas A, Thomas S, Piras G, Trevisan R, Perin PC, Bacci S, Frittitta L, Pizzuti A, Tassi V, Di Minno G, Viberti G, Trischitta V.

Nephrol Dial Transplant. 2002 Aug;17(8):1402-7.PMID: 12147786 [PubMed - indexed for MEDLINE]Related articlesFree article